MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517061067 A) filed by Metacurum Biotech AB, Umea, Sweden, on June 26, for 'anti-tgfbeta receptor 1 antibodies and uses thereof.'
Inventor(s) include Landstrom, Marene, Inga-Britt; and Schmidt, Alexej.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides antibodies or antigen-binding fragments thereof that specifically bind to the region comprising amino acid residues 126 to 133 of transforming growth factor beta receptor I (TGFR1), and to pharmaceutical compositions, kits, methods, uses and medical uses comprising the same."
The patent application was internationally filed on Dec. 18, 2023, under International application No.PCT/EP2023/086443.
Disclaimer: Curated by HT Syndication.
